Medline (MDLN) Stock Forecast & Price Target

MDLN$37.68-1.49 -3.80%
Medical - Instruments & SuppliesLarge Cap
Compare
Market cap$33.11BEnterprise value$33.11BRevenue (TTM)$30.68BMarket positionTop 25%

Score

47
Neutral
Value
42
Quality
50
Growth
49

Medline Inc. price target

MDLN
Low$37.00
Average$44.20
High$55.00
Upside vs current price+17.3%

The average target of $44.20 is +17.3% versus the current MDLN price of $37.68.

Medline Inc. analyst ratings

RatingAnalysts
Strong buy7
Buy16
Hold4
Sell0
Strong sell0
ConsensusBuy

27 analysts cover MDLN.

Medline Inc. EPS and revenue estimates

Published annual figures for MDLN on this page are 2026 EPS $1.49, 2027 EPS $1.56. Coverage under three analysts is omitted.

Fiscal yearEPS estimateRevenue estimate
2026$1.49$31.23B
2027$1.56$33.69B

Is Medline Inc. a buy or sell?

Of the 27 analysts covering Medline Inc., 23 rate it a buy (7 strong buy and 16 buy), 4 rate it a hold, and 0 rate it a sell (0 sell and 0 strong sell).

The MDLN consensus label is Buy, beside 23 buy-side ratings and 0 sell-side ratings.

The average target of $44.20 implies +17.3% versus the current price of $37.68.

The MDLN rating block is 27 published views with a Buy label. It does not tell you whether to buy or sell.

Reading the Medline Inc. forecast

A wide spread is the story on MDLN. Targets run from $37.00 to $55.00, with $44.20 as the average.

The gap from the $37.68 price to the MDLN average is +17.3%.

The MDLN rating mix is lopsided rather than split: 23 of 27 analysts are on the buy side, 4 are at hold, and 0 are on the sell side, and the published consensus is Buy.

MDLN targets have not moved much: $44.00 recently, $44.20 across the quarter.

the Medline Inc. is followed by 27 analysts, so the range matters more than any one target.

Medline Inc. forecast questions

What is the MDLN price target?

The published range for MDLN is $37.00 to $55.00, with an average of $44.20. That average is +17.3% versus the current price of $37.68.

Is Medline Inc. a buy or sell?

Of the 27 analysts covering Medline Inc., 23 rate it a buy, 4 rate it a hold, and 0 rate it a sell. The consensus is Buy, leaving MDLN at 23 buy ratings, 4 holds, and 0 sells.

What is the EPS estimate for Medline Inc.?

Analyst EPS estimates for Medline Inc.: 2026 $1.49, 2027 $1.56.

What is the revenue estimate for Medline Inc.?

Analyst revenue estimates for Medline Inc.: 2026 $31.23B, 2027 $33.69B.

How many analysts cover MDLN?

27 analysts cover MDLN. Their consensus on MDLN is Buy, across those 27.

MDLN price $37.68 -1.49 -3.80%

Insights · Forecast · Financials · Learn

Stocklytics home · Screener